The skin-brightening effect was observed through objective colorimetric assessment
Maintenance (weight reduction and long-term maintenance): The recommended maintenance dosages are 5 mg, 10 mg, or 15 mg once weekly Maintenance (OSA): The recommended maintenance dosages are 10 mg or 15 mg once weekly Maximum: 15 mg once weekly Inject subcutaneously in the abdomen, thigh, or upper arm at any time of day, with or without meals
Only pre-filled injection pens (Mounjaro and Zepbound) manufactured by Eli Lilly are approved, as compounded or reconstituted powder forms carry risks of contamination, dosing errors, and unknown ingredient stability
As of 2026, the most frequently cited conditions in these legal actions include gastroparesis, cholecystitis (gallbladder inflammation), gallstones, and intestinal obstruction